Terms: = Gastric cancer AND CD274, PDL1, 29126, ENSG00000120217, PDCD1L1, PD-L1, MGC142296, PDCD1LG1, MGC142294, B7H1, Q9NZQ7, B7-H AND Diagnosis
56 results:
1. Gastroesophageal Adenocarcinomas With Defective Mismatch Repair: Current Knowledge and Clinical Management.
Strickland MR; Lander EM; Gibson MK; Ilson DH; Ajani JA; Klempner SJ
J Natl Compr Canc Netw; 2024 Mar; 22(3):. PubMed ID: 38503041
[TBL] [Abstract] [Full Text] [Related]
2. Association of lymphocyte subsets with the efficacy and prognosis of PD‑1 inhibitor therapy in advanced gastric cancer: results from a monocentric retrospective study.
Wang X; Liu X; Dai H; Jia J
BMC Gastroenterol; 2024 Mar; 24(1):113. PubMed ID: 38491354
[TBL] [Abstract] [Full Text] [Related]
3. Perioperative or neoadjuvant chemotherapy for locally advanced gastric or gastroesophageal junction cancer: from independent evidence in the West, the East, and Japan to global collaboration.
Nakayama I; Ohashi M; Nunobe S
Chin Clin Oncol; 2024 Feb; 13(1):8. PubMed ID: 38453658
[TBL] [Abstract] [Full Text] [Related]
4. Regulation of regulatory T cells and tumor-associated macrophages in gastric cancer tumor microenvironment.
Shaopeng Z; Yang Z; Yuan F; Chen H; Zhengjun Q
Cancer Med; 2024 Jan; 13(2):e6959. PubMed ID: 38349050
[TBL] [Abstract] [Full Text] [Related]
5. gastric tubular adenocarcinoma with diffuse neutrophils infiltrating: characteristics and probable treatment strategy.
Wang B; Zhu Y; Wang S; Li Z; Wang L; Rao W; Cheng N; Chen R; Ying J; Xue L
Gastric Cancer; 2024 Jan; 27(1):86-101. PubMed ID: 38019350
[TBL] [Abstract] [Full Text] [Related]
6. Current and Emerging Role of Monoclonal Antibody-Based First-Line Treatment in Advanced Gastro-Esophageal and gastric cancer.
Désilets A; Elkhoury R; Gebai A; Tehfe M
Curr Oncol; 2023 Oct; 30(10):9304-9316. PubMed ID: 37887572
[TBL] [Abstract] [Full Text] [Related]
7. Multi-omics characteristics of tumor-associated macrophages in the tumor microenvironment of gastric cancer and their exploration of immunotherapy potential.
Cao F; Liu Y; Cheng Y; Wang Y; He Y; Xu Y
Sci Rep; 2023 Oct; 13(1):18265. PubMed ID: 37880233
[TBL] [Abstract] [Full Text] [Related]
8. What Therapeutic Biomarkers in Gastro-Esophageal Junction and gastric cancer Should a Pathologist Know About?
Kumarasinghe MP; Houghton D; Allanson BM; Price TJ
Surg Pathol Clin; 2023 Dec; 16(4):659-672. PubMed ID: 37863558
[TBL] [Abstract] [Full Text] [Related]
9. [Prognostic significance of pd-l1 expression as a potential predictor of survival in gastric cancer].
Sotnikova TN; Danilova NV; Polushkina TV; Malkov PG; Chayka AV; Khomyakov VM; Kalinin DV
Arkh Patol; 2023; 85(4):18-23. PubMed ID: 37530186
[TBL] [Abstract] [Full Text] [Related]
10. cancer immunotherapy response prediction from multi-modal clinical and image data using semi-supervised deep learning.
Wang X; Jiang Y; Chen H; Zhang T; Han Z; Chen C; Yuan Q; Xiong W; Wang W; Li G; Heng PA; Li R
Radiother Oncol; 2023 Sep; 186():109793. PubMed ID: 37414254
[TBL] [Abstract] [Full Text] [Related]
11. Early stage gastric adenocarcinoma: clinical and molecular landscapes.
Hirata Y; Noorani A; Song S; Wang L; Ajani JA
Nat Rev Clin Oncol; 2023 Jul; 20(7):453-469. PubMed ID: 37264184
[TBL] [Abstract] [Full Text] [Related]
12. Immunochemotherapy achieved a complete response for metastatic adenocarcinoma of unknown primary based on gene expression profiling: a case report and review of the literature.
Sheng J; Pan H; Han W
Front Immunol; 2023; 14():1181444. PubMed ID: 37153561
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic significances of pd-l1- and CTLA-4-positive T cells and positive correlations of immunosuppressive marker expression between cancer tissue and peripheral blood in patients with gastric cancer.
Lee KH; Kim SJ; Woo JS; Lee SY; Jhun J; Moon J; Jung YJ; Cho ML; Song KY
Front Immunol; 2023; 14():1138743. PubMed ID: 37153541
[TBL] [Abstract] [Full Text] [Related]
14. [Clinicopathological characteristics of gastric SMARCA4-deficient undifferentiated/rhabdoid carcinoma].
Wu JY; Jiang K; Yan LJ; Yin LS; Huang XZ; Jia L; Sun Y
Zhonghua Bing Li Xue Za Zhi; 2023 May; 52(5):447-453. PubMed ID: 37106285
[No Abstract] [Full Text] [Related]
15. [gastric cancer].
Racz K; Legner A; Böhme F; Sebesta C
Wien Med Wochenschr; 2023 Jun; 173(9-10):227-231. PubMed ID: 37071301
[TBL] [Abstract] [Full Text] [Related]
16. Real-World Molecular Biomarker Testing Patterns and Results for Advanced Gastroesophageal cancers in the United States.
Mehta R; Liepa AM; Zheng S; Chatterjee A
Curr Oncol; 2023 Feb; 30(2):1869-1881. PubMed ID: 36826106
[TBL] [Abstract] [Full Text] [Related]
17. Data mining combines bioinformatics discover immunoinfiltration-related gene SERPINE1 as a biomarker for diagnosis and prognosis of stomach adenocarcinoma.
Zhai Y; Liu X; Huang Z; Zhang J; Stalin A; Tan Y; Zhang F; Chen M; Shi R; Huang J; Wu C; Wu Z; Lu S; You L; Wu J
Sci Rep; 2023 Jan; 13(1):1373. PubMed ID: 36697459
[TBL] [Abstract] [Full Text] [Related]
18. Morpho-functional analysis of patient-derived xenografts reveals differential impact of gastric cancer and chemotherapy on the tumor ecosystem, affecting immune check point, metabolism, and sarcopenia.
Venkatasamy A; Guerin E; Reichardt W; Devignot V; Chenard MP; Miguet L; Romain B; Jung AC; Gross I; Gaiddon C; Mellitzer G
Gastric Cancer; 2023 Mar; 26(2):220-233. PubMed ID: 36536236
[TBL] [Abstract] [Full Text] [Related]
19. Long-term survival after immunotherapy and targeted therapy without chemotherapy in an elderly patient with HER2-positive gastroesophageal junction cancer: A case report.
Li WL; Zhang Y; Zhang XL; Du YY; Hu WQ; Zhao J
Hum Vaccin Immunother; 2022 Nov; 18(6):2121109. PubMed ID: 36166751
[TBL] [Abstract] [Full Text] [Related]
20. gastric cancer: Emerging Trends in Prevention, diagnosis, and Treatment.
Norwood DA; Montalvan-Sanchez E; Dominguez RL; Morgan DR
Gastroenterol Clin North Am; 2022 Sep; 51(3):501-518. PubMed ID: 36153107
[TBL] [Abstract] [Full Text] [Related]
[Next]
